- Home
- EDHL vs TARA Comparison
EDHL vs TARA Comparison
Compare EDHL & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDHL
- TARA
- Stock Information
- Founded
- EDHL 2021
- TARA N/A
- Country
- EDHL Hong Kong
- TARA United States
- Employees
- EDHL N/A
- TARA N/A
- Industry
- EDHL
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EDHL
- TARA Health Care
- Exchange
- EDHL NYSE
- TARA Nasdaq
- Market Cap
- EDHL 137.6M
- TARA 126.5M
- IPO Year
- EDHL 2025
- TARA N/A
- Fundamental
- Price
- EDHL $0.75
- TARA $3.33
- Analyst Decision
- EDHL
- TARA Strong Buy
- Analyst Count
- EDHL 0
- TARA 7
- Target Price
- EDHL N/A
- TARA $20.67
- AVG Volume (30 Days)
- EDHL 3.6M
- TARA 452.5K
- Earning Date
- EDHL 01-01-0001
- TARA 08-05-2025
- Dividend Yield
- EDHL N/A
- TARA N/A
- EPS Growth
- EDHL N/A
- TARA N/A
- EPS
- EDHL 0.14
- TARA N/A
- Revenue
- EDHL $2,761,798.00
- TARA N/A
- Revenue This Year
- EDHL N/A
- TARA N/A
- Revenue Next Year
- EDHL N/A
- TARA N/A
- P/E Ratio
- EDHL $5.24
- TARA N/A
- Revenue Growth
- EDHL N/A
- TARA N/A
- 52 Week Low
- EDHL $0.60
- TARA $1.60
- 52 Week High
- EDHL $6.88
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- EDHL N/A
- TARA 55.94
- Support Level
- EDHL N/A
- TARA $3.25
- Resistance Level
- EDHL N/A
- TARA $3.23
- Average True Range (ATR)
- EDHL 0.00
- TARA 0.17
- MACD
- EDHL 0.00
- TARA 0.04
- Stochastic Oscillator
- EDHL 0.00
- TARA 81.25
About EDHL EVERBRIGHT DIGITAL HOLDING
Everbright Digital Holding Ltd is an integrated marketing solutions provider in Hong Kong that is involved in the metaverse and related technologies, and is providing one-stop digital marketing services for the process of enterprise development. Its digital marketing solutions include metaverse stimulation, virtual reality (VR) and augmented reality (AR) design and creation, creative event planning and management, IP character creation and social media marketing.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).